| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
phenotype | 0.120 | None | 0.500 | 0 | 0 | 2003 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2018 | 2018 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
forkhead box P3 | 0.368 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2018 | 2018 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
phenotype | 0.170 | None | 0.857 | 0 | 0 | 2007 | 2018 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
phenotype | 0.200 | None | 0.962 | 0 | 0 | 1981 | 2019 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
filamin A | 0.419 | 0.846 | 1.00 |
|
phenotype | 0.140 | None | 1.000 | 0 | 0 | 2011 | 2018 | ||||||||
|
fms related receptor tyrosine kinase 1 | 0.419 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
phenotype | 0.500 | strong | 0.968 | 0 | 0 | 1999 | 2019 |